DILTIAZEM HYDROCHLORIDE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69097-997 -
Package NDC
69097-997-02 -
Package NDC
69097-997-05 -
Application number
ANDA216327 -
SPL ID
8e10fac2-bb4b-4d93-ad8c-4fd93278a91e -
SPL set ID
bce61158-201d-458c-be0c-9bdd2d3a0bec -
UNII
OLH94387TE -
RxCUI
830874 -
RxCUI
830877 -
RxCUI
830879 -
RxCUI
830882 -
RxCUI
830897 -
RxCUI
830900
What the source publishes
- Labeler
- Cipla USA, Inc.
- Active ingredients
- diltiazem hydrochloride
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "DILTIAZEM HYDROCHLORIDE",
"splId": "8e10fac2-bb4b-4d93-ad8c-4fd93278a91e",
"labels": [
{
"setId": "bce61158-201d-458c-be0c-9bdd2d3a0bec",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bce61158-201d-458c-be0c-9bdd2d3a0bec",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bce61158-201d-458c-be0c-9bdd2d3a0bec"
}
],
"routes": [
"ORAL"
],
"labeler": "Cipla USA, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-997-02)",
"package_ndc": "69097-997-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20230612"
},
{
"sample": false,
"description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-997-05)",
"package_ndc": "69097-997-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20230612"
}
],
"productId": "69097-997_8e10fac2-bb4b-4d93-ad8c-4fd93278a91e",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "69097-997",
"deaSchedule": null,
"genericName": "diltiazem hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DILTIAZEM HYDROCHLORIDE",
"strength": "420 mg/1"
}
],
"applicationNumber": "ANDA216327",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230612",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"OLH94387TE"
],
"rxcui": [
"830874",
"830877",
"830879",
"830882",
"830897",
"830900"
],
"spl_set_id": [
"bce61158-201d-458c-be0c-9bdd2d3a0bec"
],
"manufacturer_name": [
"Cipla USA, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69097-997_8e10fac2-bb4b-4d93-ad8c-4fd93278a91e"